Rapid Therapeutic Science Stock Price on November 27, 2024

RTSL Stock  USD 0  0.00  0.00%   
If you're considering investing in Rapid Pink Sheet, it is important to understand the factors that can impact its price. As of today, the current price of Rapid Therapeutic stands at 0, as last reported on the 11th of December 2024, with the highest price reaching 0 and the lowest price hitting 0 during the day. Rapid Therapeutic Science maintains Sharpe Ratio (i.e., Efficiency) of -0.13, which implies the firm had a -0.13% return per unit of risk over the last 3 months. Rapid Therapeutic Science exposes sixteen different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Rapid Therapeutic's Risk Adjusted Performance of (0.12), variance of 91.03, and Coefficient Of Variation of (572.44) to confirm the risk estimate we provide.
  
Rapid Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.126

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsRTSL

Estimated Market Risk

 6.3
  actual daily
56
56% of assets are less volatile

Expected Return

 -0.79
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.13
  actual daily
0
Most of other assets perform better
Based on monthly moving average Rapid Therapeutic is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Rapid Therapeutic by adding Rapid Therapeutic to a well-diversified portfolio.

Related Headline

EnVVeno Medical Headline on 27th of November 2024

Interviews with participating patients from the VenoValve U.S. Pivotal Trial Webcast replay from with the presenting Primary Investigators Presentation with data from the VenoValve U.S. Pivotal Trial Access the Recap Website Here IRVINE, CA ACCESSWIRE ...

Rapid Therapeutic Valuation on November 27, 2024

It is possible to determine the worth of Rapid Therapeutic on a given historical date. On November 27, 2024 Rapid was worth 0.001 at the beginning of the trading date compared to the closed value of 0.001. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Rapid Therapeutic pink sheet. Still, in general, we apply an absolute valuation method to find Rapid Therapeutic's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Rapid Therapeutic where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Rapid Therapeutic's related companies.
 Open High Low Close Volume
  0    0    0    0    1.00  
11/27/2024
  0    0    0    0    1.00  
  0    0    0    0    1.00  
Backtest Rapid Therapeutic  |  Rapid Therapeutic History  |  Rapid Therapeutic Valuation   PreviousNext  
Open Value
0.001
0.001
Closing Value
18.90
Upside

Rapid Therapeutic Trading Date Momentum on November 27, 2024

On November 29 2024 Rapid Therapeutic Science was traded for  0  at the closing time. The top price for the day was 0  and the lowest listed price was  0 . There was no trading activity during the period 1.0. Lack of trading volume on November 29, 2024 did not cause price change. The trading delta at closing time against the current closing price is 0.00% .

Rapid Therapeutic Science Fundamentals Correlations and Trends

By evaluating Rapid Therapeutic's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Rapid Therapeutic's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Rapid financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Rapid Therapeutic Pink Sheet history

Rapid Therapeutic investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Rapid is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Rapid Therapeutic Science will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Rapid Therapeutic stock prices may prove useful in developing a viable investing in Rapid Therapeutic
Rapid Therapeutic Science Laboratories, Inc. operates as a biotech company. Rapid Therapeutic Science Laboratories, Inc. was a former subsidiary of Texas Mdi, Inc. Rapid Therapeutic operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 8 people.

Rapid Therapeutic Pink Sheet Technical Analysis

Rapid Therapeutic technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
A focus of Rapid Therapeutic technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Rapid Therapeutic trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Rapid Therapeutic Period Price Range

Low
December 11, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Rapid Therapeutic Science cannot be verified against its exchange. Please verify the symbol is currently traded on PINK Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Rapid Therapeutic December 11, 2024 Market Strength

Market strength indicators help investors to evaluate how Rapid Therapeutic pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Rapid Therapeutic shares will generate the highest return on investment. By undertsting and applying Rapid Therapeutic pink sheet market strength indicators, traders can identify Rapid Therapeutic Science entry and exit signals to maximize returns

Rapid Therapeutic Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Rapid Therapeutic's price direction in advance. Along with the technical and fundamental analysis of Rapid Pink Sheet historical price patterns, it is also worthwhile for investors to track various predictive indicators of Rapid to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Other Information on Investing in Rapid Pink Sheet

Rapid Therapeutic financial ratios help investors to determine whether Rapid Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Rapid with respect to the benefits of owning Rapid Therapeutic security.